Skip to main content
. 2020 Dec;9(12):7405–7414. doi: 10.21037/tcr-20-2734

Table 1. Demographic and clinical characteristics of the breast cancer study participants.

Characteristics Study group P
Intervention (n=66) Control (n=67)
Age (years) 0.6427
   <40 2 (3.0%) 5 (7.5%)
   40–49 25 (37.9%) 27 (40.3%)
   50–60 30 (45.5%) 28 (41.8%)
   >60 9 (13.6%) 7 (10.4%)
Body weight (kg) 51.2±11.4 52.9±12.5 0.4937
BMI 24.1±4.4 22.4±5.1 0.2716
Marital status 0.2077
   Married 49 (74.2%) 56 (83.6%)
   Single/widowed/divorced 17 (25.8%) 11 (16.4%)
No. of children 0.2187
   ≤2 54 (81.8%) 48 (71.6%)
   >2 12 (18.2%) 19 (28.4%)
Employment status 0.4799
   No 38 (57.6%) 43 (64.2%)
   Yes 28 (42.4%) 24 (35.8%)
Education level 0.5657
   High school and below 46 (69.7%) 50 (74.6%)
   College and above 20 (30.3%) 17 (25.4%)
Surgery type 0.3755
   Mastectomy 23 (34.8%) 29 (43.3%)
   Lumpectomy 43 (65.2%) 38 (56.7%)
   Days since surgery 62.3±30.4 58.4±34.6 0.1937
   Days since first chemotherapy 16.7±12.8 19.2±14.2 0.3273
Time of having breast cancer 0.4889
   ≤1year 29 (43.9%) 34 (50.7%)
   >1 year 37 (56.1%) 33 (49.3%)
Breast cancer stages 0.7275
   I 9 (13.6%) 7 (10.4%)
   II 30 (45.5%) 32 (47.8%)
   III 18 (27.3%) 15 (22.4%)
   IV 9 (13.6%) 13 (19.4%)

Values were expressed as n (percentage, %) or mean ± SD. P values for each group were derived from either unpaired t-test or Mann-Whitney test as appropriate. Chi-square test or Fisher’s exact test was used for assessing distribution of observations or phenomena between different groups. BMI, body mass index.